earnings

Biogen isn’t concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
Biogen isn’t concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
CNBC
Biogen
earnings
Pharma CEOs
Chris Viehbacher
Eli Lilly
Alzheimer's disease
Leqembi
donanemab
Flag link:
AstraZeneca overtakes Pfizer as crunch week for UK pharma looms
AstraZeneca overtakes Pfizer as crunch week for UK pharma looms
The Guardian, UK
AstraZeneca
Pfizer
earnings
Flag link:
Busy with 3 program launches this year, Biogen trims pipeline
Busy with 3 program launches this year, Biogen trims pipeline
Fierce Biotech
Biogen
stroke
gene therapy
ophthalmology
earnings
Flag link:
Novartis, helped by cost cuts, raises full-year outlook
Novartis, helped by cost cuts, raises full-year outlook
Reuters
Novartis
earnings
Flag link:
Why Medtronic Stock Soared More Than 4% Higher Today
Why Medtronic Stock Soared More Than 4% Higher Today
Motley Fool
Medtronic
Medtech
earnings
Flag link:
Abbott sales 18% fall due to anticipation of COVID testing sales declines
Abbott sales 18% fall due to anticipation of COVID testing sales declines
Medical Marketing and Media
Abbott Labs
earnings
COVID-19
Medtech
Flag link:
J&J records $130M restructuring expense in Q1 overhaul of infectious disease unit
J&J records $130M restructuring expense in Q1 overhaul of infectious disease unit
Fierce Biotech
JNJ
Janssen
earnings
restructuring
infectious disease
Flag link:
Regeneron expects $56M IPR&D charge tied to cell therapy pact
Regeneron expects $56M IPR&D charge tied to cell therapy pact
Fierce Biotech
Regeneron
earnings
R&D
Sonoma Biotherapeutics
Flag link:
BioNTech's COVID-19 vaccine revenue forecasts lower than expected
BioNTech's COVID-19 vaccine revenue forecasts lower than expected
Biopharma Reporter
BioNTech
earnings
COVID-19
vaccines
Flag link:
Bayer grapples with Eylea sales slowdown, sees trend continuing in 2023
Bayer grapples with Eylea sales slowdown, sees trend continuing in 2023
Fierce Pharma
Bayer
earnings
Eylea
Flag link:
BeiGene doubles sales as Brukinsa, tislelizumab gear up for key launches
BeiGene doubles sales as Brukinsa, tislelizumab gear up for key launches
Fierce Pharma
BeiGene
Brukinsa
earnings
tislelizumab
Flag link:
Moderna's Cancer Vaccine Wins An FDA Boon, But Shares Drop On Mixed Earnings
Moderna's Cancer Vaccine Wins An FDA Boon, But Shares Drop On Mixed Earnings
Investors Business Daily
Moderna Therapeutics
earnings
MRNA
vaccines
FDA
cancer vaccines
Flag link:
Pharma Giant Pfizer Looks Strong for Investors, Despite COVID Sales Drop
Pharma Giant Pfizer Looks Strong for Investors, Despite COVID Sales Drop
Motley Fool
Pfizer
earnings
vaccines
COVID-19
Flag link:
Medtronic boosts full-year outlook as supply challenges subside
Medtronic boosts full-year outlook as supply challenges subside
Medtech Dive
Medtronic
Medtech
devices
earnings
Flag link:
Seagen mum on Merck buyout rumors as it bats for blockbuster with Adcetris
Seagen mum on Merck buyout rumors as it bats for blockbuster with Adcetris
BioSpace
Seagen
earnings
Merck
M&A
Adcetris
Flag link:
Biogen CEO says company 'lost its way,' cuts $125M MS partnership amid declining revenue
Biogen CEO says company 'lost its way,' cuts $125M MS partnership amid declining revenue
Endpoints
Biogen
InnoCare Pharma
orelabrutinib
earnings
Flag link:
Lower COVID sales weigh on AZ in fourth quarter
Lower COVID sales weigh on AZ in fourth quarter
Pharmaphorum
AstraZeneca
COVID-19
vaccines
earnings
Flag link:
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints
PharmaLive
Teva Pharmaceutical
earnings
Flag link:
Vaccines slip, Dupixent climbs for Sanofi as it readies multiple launches in 2023
Vaccines slip, Dupixent climbs for Sanofi as it readies multiple launches in 2023
Fierce Pharma
Sanofi
Dupixent
earnings
Flag link:
In showdown with Roche, Regeneron gears up for potential Eylea expansion amid Covid decline
In showdown with Roche, Regeneron gears up for potential Eylea expansion amid Covid decline
Endpoints
Regeneron
earnings
Eylea
Flag link:

Pages